Summary: The Dow closed up 131 points today, rallying after yesterday's slide. Tonight, Cramer's weighing in on whether the situation in Europe could finally have bottomed and what that means for stocks in the U.S. Then, Jim's talking with the CEO of AGN - the company behind Botox - to find out more about the drug data that drove the stock down yesterday. Plus, an impending drug cliff? The CEO of CRL is breaking down how the sequester might impact development of new medications.
